Perelman School Of Medicine University Of Pennsylvania

A new retrospective analysis has added to building evidence that suggests chimeric antigen receptor T-cell therapy does not directly cause secondary malignancies.

NIH’s decision to cut what it pays universities and other entities for indirect costs associated with scientific research would have immediate and far-reaching consequences, according to many academic institutions and professional societies.

SAN DIEGO — Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood cancers, according to retrospective data presented at ASH Annual Meeting and Exposition. Patients with commercial insurance and Medicaid had prescriptions rejected more often than patients with Medicare.

SAN DIEGO — Etavopivat reduced the annualized vaso-occlusive crises rate vs. placebo for people with sickle cell disease, according to study data presented at ASH Annual Meeting and Exposition.

SAN DIEGO — Hydroxyurea conferred benefit to children and adults with hemoglobin SC disease, according to study results presented at ASH Annual Meeting and Exposition.

I’m Luca Paruzzo, MD, a hematologist/oncologist working as a postdoctoral fellow at University of Pennsylvania under the mentorship of Marco Ruella, MD.

Multiple studies published since this summer suggest chimeric antigen receptor T-cell therapies are comparably effective in real-world settings as they have been in pivotal clinical trials.

Although research has shown diversity in health care can enhance patient satisfaction, clinical outcomes and improve access to care, women and historically underrepresented groups still represent a minority in orthopedics.

The AI revolution already has transformed delivery of cancer care.

When Danielle Mitchell told an acquaintance about her mission to better represent Black women in the clinical workforce, the woman responded with a personal story.